Top compounds associated with response to TTPAL


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.03
mRNA PDMP CTRPv2 pan-cancer AAC -0.086 0.03
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.084 0.03
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.11 0.03
mRNA Crizotinib CCLE pan-cancer AAC -0.1 0.03
mRNA lovastatin CTRPv2 pan-cancer AAC 0.083 0.03
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.11 0.03
mRNA PD-0332991 CCLE pan-cancer AAC -0.1 0.03
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.081 0.03
Download CSV